High frequency of neurexin 1β signal peptide structural variants in patients with autism

Neuroscience Letters

Volumn 409, Issue 1, 2006, Pages 10-13

  Feng, Jinong ^a   Schroer, Richard ^b   Yan, Jin ^a   Song, Wenjia ^a   Yang, Chunmei ^a   Bockholt, Anke ^a   Cook Jr , Edwin H ^c   Skinner, Cindy ^b   Schwartz, Charles E ^b   Sommer, Steve S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b GREENWOOD GENETIC CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Neurexin genes; Autism; Mutation detection; NLGN4 gene

Indexed keywords

NEUREXIN; NEUREXIN 1BETA; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ARTICLE; AUTISM; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; UNITED STATES;

ABNORMALITIES, MULTIPLE; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; DNA TRANSPOSABLE ELEMENTS; EXONS; FEMALE; HUMANS; MALE; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; PENETRANCE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PSYCHIATRIC STATUS RATING SCALES; UNITED STATES;

EID: 33750079257     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.08.017     Document Type: Article

References (27)

1. Buzin C.H., Wen C.Y., Nguyen V.Q., Nozari G., Mengos A., Li X., Chen J.S., Liu Q., Gatti R.A., Fujimura F.K., and Sommer S.S. Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: Evidence that the scanning conditions are generic. BioTechniques 28 (2000) 746-753
2. Cook E.H.J., Courchesne R.Y., Cox N.J., Lord C., Gonen D., Guter S.J., Lincoln A., Nix K., Haas R., Leventhal B.L., and Courchesne E. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am. J. Hum. Genet. 62 (1998) 1077-1083
3. Dean C., Scholl F.G., Choih J., DeMaria S., Berger J., Isacoff E., and Scheiffele P. Neurexin mediates the assembly of presynaptic terminals. Nat. Neurosci. 6 (2003) 708-716
4. DiLavore P.C., Lord C., and Rutter M. The pre-linguistic autism diagnostic observation schedule. J Autism Dev. Disord. 25 (1995) 355-379
5. J. Feng, J. Yan, W. Li, J. Chen, S.S. Sommer, Candidate gene analyses by scanning or brute force fluorescent sequencing; A comparison of DOVAM-S with gel-based and capillary-based sequencing, Genet. Test. (in press).
6. Garner C.C., Nash J., and Huganir R.L. PDZ domains in synapse assembly and signaling. Trends Cell Biol. 10 (2000) 274-280
7. Hortsch M., and Meyer D.I. Transfer of secretory proteins through the membrane of the endoplasmic reticulum. Int. Rev. Cytol. 102 (1986) 215-242
8. Ichtchenko K., Hata Y., Nguyen T., Ullrich B., Missler M., Moomaw C., and Sudhof T.C. Neuroligin 1: A splice site-specific ligand for beta-neurexins. Cell 81 (1995) 435-443
9. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., and Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34 (2003) 27-29
10. Kleiderlein J.J., Nisson P.E., Jessee J., Li W.B., Becker K.G., Derby M.L., Ross C.A., and Margolis R.L. CCG repeats in cDNAs from human brain. Hum. Genet. 103 (1998) 666-673
11. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., Raynaud M., Ronce N., Lemonnier E., Calvas P., Laudier B., Chelly J., Fryns J.P., Ropers H.H., Hamel B.C., Andres C., Barthelemy C., Moraine C., and Briault S. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 74 (2004) 552-557
12. Liu Q., Feng J., Buzin C., Wen C., Nozari G., Mengos A., Nguyen V., Liu J., Crawford F., Fujimura F.K., and Sommer S.S. Detection of virtually all mutations-SSCP (DOVAM-S): A rapid method for mutation scanning with virtually 100% sensitivity. BioTechniques 26 (1999) 932-942
13. Lobo-Menendez F., Sossey-Alaoui K., Bell J.M., Copeland-Yates S.A., Plank S.M., Sanford S.O., Skinner C., Simensen R.J., Schroer R.J., and Michaelis R.C. Absence of MeCP2 mutations in patients from the South Carolina autism project. Am. J. Med. Genet. B Neuropsychiatr. Genet. 117 (2003) 97-101
14. Lord C., Rutter M., and LeCouteur A. Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Dis. 24 (1994) 659-685
15. Lord C., and Schopler E. The role of age at assessment, developmental level, and test in the stability of intelligence scores in young autistic children. J. Autism Dev. Disord. 19 (1989) 483-499
16. Missler M., and Sudhof T.C. Neurexins: Three genes and 1001 products. Trends Genet. 14 (1998) 20-26
17. Rowen L., Young J., Birditt B., Kaur A., Madan A., Philipps D.L., Qin S., Minx P., Wilson R.K., Hood L., and Graveley B.R. Analysis of the human neurexin genes: Alternative splicing and the generation of protein diversity. Genomics 79 (2002) 587-597
18. Schopler E., Reichler R.J., DeVellis R.F., and Daly K. Toward objective classification of childhood autism: Childhood autism rating scale (CARS). J. Autism Dev. Disord. 10 (1980) 91-103
19. Schroer R.J., Phelan M.C., Michaelis R.C., Crawford E.C., Skinner S.A., Cuccaro M., Simensen R.J., Bishop J., Skinner C., Fender D., and Stevenson R.E. Autism and maternally derived aberrations of chromosome 15q. Am. J. Med. Genet. 76 (1998) 327-336
20. Shibayama A., Cook Jr. E.H., Feng J., Glanzmann C., Yan J., Craddock N., Jones I.R., Goldman D., Heston L.L., and Sommer S.S. MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. Am. J Med. Genet. B Neuropsychiatr. Genet. 128 (2004) 50-53
21. Smalley S.L., Tanguay P.E., Smith M., and Gutierrez G. Autism and tuberous sclerosis. J. Autism Dev. Disord. 22 (1992) 339-355
22. Sparrow S.S., Balla D.A., and Cicchetti D.V. Vineland Adaptive Behavior Scales (1984), American Guidance Service, Circle Pines, MN
23. Tabuchi K., and Sudhof T.C. Structure and evolution of neurexin genes: Insight into the mechanism of alternative splicing. Genomics 79 (2002) 849-859
24. Ullrich B., Ushkaryov Y.A., and Sudhof T.C. Cartography of neurexins: More than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons. Neuron 14 (1995) 497-507
25. Ushkaryov Y.A., Hata Y., Ichtchenko K., Moomaw C., Afendis S., Slaughter C.A., and Sudhof T.C. Conserved domain structure of beta-neurexins. Unusual cleaved signal sequences in receptor-like neuronal cell-surface proteins. J Biol. Chem. 269 (1994) 11987-11992
26. Von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 14 (1986) 4683-4690
27. Yan J., Oliveira G., Coutinho A.M., Yang C., Feng J., Katz C., Sram J., Bockholt A., Jones I.R., Craddock N., Cook E.H.J., Vicente A.M., and Sommer S.S. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol. Psychiatr. 10 (2005) 329-335